In patients with RA, the level of M-CSF is increased in the serum and synovial fluid5, and inhibiting c-FMS activation attenuates the progression of joint inflammation and bone erosion in animal models of arthritis6. This evidence concerns the gene CSF1 and rheumatoid arthritis.